Cefepime-dextrose 2 GM/50 MLS
Ended Awarded
- Contract number
- SPE2DB25FJT22
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,354
Award facts
- Contract value 100% obligated
- $7,354.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,354.05 to AmerisourceBergen Drug Corp for the supply of Cefepime-Dextrose 2 GM/50 MLS, an intravenous antibiotic formulation used for bacterial infections in military and federal healthcare settings. The contract, executed on September 3, 2025, with an ultimate completion date of September 4, 2025, employs firm fixed pricing under a non-competitive, non-set-aside delivery order arrangement. Performance will occur at the vendor's corporate headquarters in Conshohocken, Pennsylvania.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle for global military healthcare programs, enabling the company to supply a diverse range of brand-name and generic medications, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to meet federal medical procurement requirements through competitive awards and successfully fulfills critical supply needs across multiple therapeutic domains for the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FJT22?
SPE2DB25FJT22 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FJT22 worth?
The government has obligated $7,354 on SPE2DB25FJT22.
Is contract SPE2DB25FJT22 an order under another contract?
Yes. SPE2DB25FJT22 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJT22 competed?
The extent of competition for SPE2DB25FJT22 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award